← All stocks

Ionis Pharmaceuticals Inc

IONSPharmaceuticalsLatest filing used: 2026-11-09Filings on SEC EDGAR ↗

Fair value per share

No filings-based value

The filings alone are probably missing something here: the company's typical cash earnings in the filings are negative.

Last close

$29.06

Nov 13, 2026

How we decide

Ten years of results

Revenue

$944M in FY2025, up 34% on the year before

FY2016: $347MFY2017: $508MFY2018: $600MFY2019: $1.1BFY2020: $729MFY2021: $810MFY2022: $587MFY2023: $788MFY2024: $705MFY2025: $944M$750M$1.5BFY16FY19FY22FY25$944M
Show as table
YearRevenue
FY2016$347M
FY2017$508M
FY2018$600M
FY2019$1.1B
FY2020$729M
FY2021$810M
FY2022$587M
FY2023$788M
FY2024$705M
FY2025$944M

Cash earnings as a share of sales

-31.8% of sales in FY2025

FY2022: -54.1%FY2023: -55.0%FY2024: -68.3%FY2025: -31.8%-68%16%100%FY16FY19FY22FY25-32%
Show as table
YearCash earnings as a share of sales
FY2016–
FY2017–
FY2018–
FY2019–
FY2020–
FY2021–
FY2022-54.1%
FY2023-55.0%
FY2024-68.3%
FY2025-31.8%

Shares outstanding

Share count rose 32% over 9 years

FY2016: 121MFY2017: 126MFY2018: 134MFY2019: 153MFY2020: 140MFY2021: 141MFY2022: 142MFY2023: 143MFY2024: 150MFY2025: 160M0100M200MFY16FY19FY22FY25160M
Show as table
YearShares outstanding
FY2016121M
FY2017126M
FY2018134M
FY2019153M
FY2020140M
FY2021141M
FY2022142M
FY2023143M
FY2024150M
FY2025160M

No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-09. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.